Membrane Proteome of Invasive Retinoblastoma: Differential Proteins and Biomarkers

Ravikanth Danda, Kalaivani Ganapathy, Gajanan Sathe, Anil K. Madugundu, Uma Maheswari Krishnan, Vikas Khetan, Pukhraj Rishi, Harsha Gowda, Akhilesh Pandey, Krishnakumar Subramanian (Lead / Corresponding author), T. S.Keshava Prasad (Lead / Corresponding author), Sailaja V. Elchuri (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


Purpose: Retinoblastoma (RB) is a pediatric ocular cancer which is caused due to the aberrations in the RB1 gene. The changes in the membrane proteomics would help in understanding the development of the retinoblastoma and could identify candidates for biomarkers and therapy. Experimental design: Quantitative proteomics is performed on the enriched membrane fractions from pooled normal retina (n = 5) and pooled retinoblastoma tissues (n = 5). The proteins are tryptic-digested and tagged with iTRAQ labels. Orbitrap mass spectrometry is used to analyze and quantify the deregulated membrane proteins involved in the RB tumor progression. Immunohistochemistry (IHC) is used to further validate few of the differentially expressed proteins. Results: A total of 3122 proteins are identified of which, 663 proteins are found to be deregulated with ≥two fold change in the RB tumor compared to the retina. 282 proteins are upregulated and 381 are downregulated with ≥2 peptide identifications. Bioinformatic analysis revealed that, most of the proteins are involved in the transport, cellular communication, and growth. Overexpression of lamin B1 (LMNB1) and transferrin receptor (TFRC) are observed in RB tumors using IHC. Conclusion and clinical relevance: The present study, is the first comprehensive quantitative membrane proteomic atlas of the differentially regulated proteins in RB compared to the retina. LMNB1 and TFRC could be potential biomarkers for this childhood cancer.

Original languageEnglish
Article number1700101
Number of pages5
JournalProteomics - Clinical Applications
Issue number5
Early online date13 Jun 2018
Publication statusPublished - 11 Sept 2018


  • LMNB1
  • mass spectrometry
  • membrane proteomics
  • retinoblastoma
  • TFRC

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Membrane Proteome of Invasive Retinoblastoma: Differential Proteins and Biomarkers'. Together they form a unique fingerprint.

Cite this